Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer

Published:2021-06-29 Issue:16 Volume:25 Page:7890-7900
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Muilwijk Tim¹²^ORCID,Akand Murat¹²^ORCID,Van der Aa Frank¹^ORCID,De Coninck Vincent³^ORCID,Claessens Marc³,Hente Robert³,Eckstein Markus⁴^ORCID,Allory Yves⁵^ORCID,Libbrecht Louis⁶⁷^ORCID,Joniau Steven¹^ORCID,Gevaert Thomas²⁸^ORCID

Affiliation:

1. Department of Urology University Hospitals Leuven Leuven Belgium

2. Organ Systems KU Leuven Leuven Belgium

3. Department of Urology AZ Klina Brasschaat Belgium

4. Department of Pathology University Hospital Erlangen Erlangen Germany

5. Department of Pathology Curie Institute Paris France

6. Department of Pathology AZ Groeninge Kortrijk Belgium

7. Department of Pathology University Hospital Saint‐Luc Brussels Belgium

8. Department of Pathology AZ Klina Brasschaat Belgium

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16712

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

3. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

4. Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?

5. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced bladder cancer detection: Innovations in biomarkers and nanobiosensors;Sensing and Bio-Sensing Research;2024-08

2. Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression;European Urology Open Science;2024-08

3. Intermediate filament proteins are reliable immunohistological biomarkers to help diagnose multiple tissue‐specific diseases;Anatomia, Histologia, Embryologia;2023-06-16

4. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder;Experimental and Molecular Pathology;2023-06

5. Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer;International Journal of Molecular Sciences;2023-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3